These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38732837)

  • 1. Faecal Volatile Organic Compound Analysis in De Novo Paediatric Inflammatory Bowel Disease by Gas Chromatography-Ion Mobility Spectrometry: A Case-Control Study.
    Vermeer E; Jagt JZ; Stewart TK; Covington JA; Struys EA; de Jonge R; de Boer NKH; de Meij TGJ
    Sensors (Basel); 2024 Apr; 24(9):. PubMed ID: 38732837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Faecal volatile organic compounds analysis using field asymmetric ion mobility spectrometry: non-invasive diagnostics in paediatric inflammatory bowel disease.
    van Gaal N; Lakenman R; Covington J; Savage R; de Groot E; Bomers M; Benninga M; Mulder C; de Boer N; de Meij T
    J Breath Res; 2017 Nov; 12(1):016006. PubMed ID: 28439048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Faecal volatile organic compounds differ according to inflammatory bowel disease sub-type, severity, and response to treatment in paediatric patients.
    Belnour S; Slater R; Tharmaratnam K; Karl-Heinz Auth M; Muhammed R; Spray C; Wang D; Zeeshan Ijaz U; Probert C; Allen S
    United European Gastroenterol J; 2024 Jul; 12(6):780-792. PubMed ID: 38922802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The faecal scent of inflammatory bowel disease: Detection and monitoring based on volatile organic compound analysis.
    Bosch S; Wintjens DSJ; Wicaksono A; Kuijvenhoven J; van der Hulst R; Stokkers P; Daulton E; Pierik MJ; Covington JA; de Meij TGJ; de Boer NKH
    Dig Liver Dis; 2020 Jul; 52(7):745-752. PubMed ID: 32402741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimized Sampling Conditions for Fecal Volatile Organic Compound Analysis by Means of Field Asymmetric Ion Mobility Spectrometry.
    Bosch S; El Manouni El Hassani S; Covington JA; Wicaksono AN; Bomers MK; Benninga MA; Mulder CJJ; de Boer NKH; de Meij TGJ
    Anal Chem; 2018 Jul; 90(13):7972-7981. PubMed ID: 29860824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-invasive exhaled volatile organic biomarker analysis to detect inflammatory bowel disease (IBD).
    Arasaradnam RP; McFarlane M; Daulton E; Skinner J; O'Connell N; Wurie S; Chambers S; Nwokolo C; Bardhan K; Savage R; Covington J
    Dig Liver Dis; 2016 Feb; 48(2):148-53. PubMed ID: 26682719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous Assessment of Urinary and Fecal Volatile Organic Compound Analysis in De Novo Pediatric IBD.
    El Manouni El Hassani S; Bosch S; Lemmen JPM; Brizzio Brentar M; Ayada I; Wicaksono AN; Covington JA; Benninga MA; de Boer NKH; de Meij TGJ
    Sensors (Basel); 2019 Oct; 19(20):. PubMed ID: 31623289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gas Chromatography-Sensor System Aids Diagnosis of Inflammatory Bowel Disease, and Separates Crohn's from Ulcerative Colitis, in Children.
    Slater R; Tharmaratnam K; Belnour S; Auth MK; Muhammed R; Spray C; Wang D; de Lacy Costello B; García-Fiñana M; Allen S; Probert C
    Sensors (Basel); 2024 Aug; 24(15):. PubMed ID: 39124126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease.
    Ahmed I; Greenwood R; Costello B; Ratcliffe N; Probert CS
    Aliment Pharmacol Ther; 2016 Mar; 43(5):596-611. PubMed ID: 26806034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation Between Pediatric Irritable Bowel Syndrome and Inflammatory Bowel Disease Based on Fecal Scent: Proof of Principle Study.
    Bosch S; van Gaal N; Zuurbier RP; Covington JA; Wicaksono AN; Biezeveld MH; Benninga MA; Mulder CJ; de Boer NKH; de Meij TGJ
    Inflamm Bowel Dis; 2018 Oct; 24(11):2468-2475. PubMed ID: 29788410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Faecal and Serum Metabolomics in Paediatric Inflammatory Bowel Disease.
    Kolho KL; Pessia A; Jaakkola T; de Vos WM; Velagapudi V
    J Crohns Colitis; 2017 Mar; 11(3):321-334. PubMed ID: 27609529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomic analysis of breath volatile organic compounds reveals unique breathprints in children with inflammatory bowel disease: a pilot study.
    Patel N; Alkhouri N; Eng K; Cikach F; Mahajan L; Yan C; Grove D; Rome ES; Lopez R; Dweik RA
    Aliment Pharmacol Ther; 2014 Sep; 40(5):498-507. PubMed ID: 25041596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variability of core microbiota in newly diagnosed treatment-naïve paediatric inflammatory bowel disease patients.
    de Meij TGJ; de Groot EFJ; Peeters CFW; de Boer NKH; Kneepkens CMF; Eck A; Benninga MA; Savelkoul PHM; van Bodegraven AA; Budding AE
    PLoS One; 2018; 13(8):e0197649. PubMed ID: 30102706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surrogate Markers of Intestinal Inflammation in Paediatric Patients with Inflammatory Bowel Disease.
    Shentova R; Baycheva M; Kofinova D; Hadjiiski P; Yaneva P
    Folia Med (Plovdiv); 2020 Jun; 62(2):271-275. PubMed ID: 32666743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Faecal gas analysis by electronic nose as novel, non-invasive method for assessment of active and quiescent paediatric inflammatory bowel disease: Proof of principle study.
    de Meij TG; de Boer NK; Benninga MA; Lentferink YE; de Groot EF; van de Velde ME; van Bodegraven AA; van der Schee MP
    J Crohns Colitis; 2014 Sep; ():. PubMed ID: 25248313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD.
    De Preter V; Machiels K; Joossens M; Arijs I; Matthys C; Vermeire S; Rutgeerts P; Verbeke K
    Gut; 2015 Mar; 64(3):447-58. PubMed ID: 24811995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory bowel disease and patterns of volatile organic compounds in the exhaled breath of children: A case-control study using Ion Molecule Reaction-Mass Spectrometry.
    Monasta L; Pierobon C; Princivalle A; Martelossi S; Marcuzzi A; Pasini F; Perbellini L
    PLoS One; 2017; 12(8):e0184118. PubMed ID: 28859138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of Exhaled Breath Volatile Organic Compounds in Inflammatory Bowel Disease: A Pilot Study.
    Hicks LC; Huang J; Kumar S; Powles ST; Orchard TR; Hanna GB; Williams HR
    J Crohns Colitis; 2015 Sep; 9(9):731-7. PubMed ID: 26071410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breath Analysis Using eNose and Ion Mobility Technology to Diagnose Inflammatory Bowel Disease-A Pilot Study.
    Tiele A; Wicaksono A; Kansara J; Arasaradnam RP; Covington JA
    Biosensors (Basel); 2019 Apr; 9(2):. PubMed ID: 31013848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The microbiome reflects diagnosis and predicts disease severity in paediatric onset inflammatory bowel disease.
    Malham M; Lilje B; Houen G; Winther K; Andersen PS; Jakobsen C
    Scand J Gastroenterol; 2019 Aug; 54(8):969-975. PubMed ID: 31329473
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.